Your browser doesn't support javascript.
loading
Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10+ advanced non-small cell lung cancer.
Blumenschein, George R; Devarakonda, Siddhartha; Johnson, Melissa; Moreno, Victor; Gainor, Justin; Edelman, Martin J; Heymach, John V; Govindan, Ramaswamy; Bachier, Carlos; Doger de Spéville, Bernard; Frigault, Matthew J; Olszanski, Anthony J; Lam, Vincent K; Hyland, Natalie; Navenot, Jean-Marc; Fayngerts, Svetlana; Wolchinsky, Zohar; Broad, Robyn; Batrakou, Dzmitry; Pentony, Melissa M; Sanderson, Joseph P; Gerry, Andrew; Marks, Diane; Bai, Jane; Holdich, Tom; Norry, Elliot; Fracasso, Paula M.
Afiliação
  • Blumenschein GR; Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA gblumens@mdanderson.org.
  • Devarakonda S; Medical Oncology, Washington University School of Medicine, St Louis, Missouri, USA.
  • Johnson M; Lung Cancer Research and Drug Development, Sarah Cannon Research Institute at Tennessee Oncology, Nashville, Tennessee, USA.
  • Moreno V; START Madrid-FJD, Fundación Jiménez Díaz University Hospital, Madrid, Spain.
  • Gainor J; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Edelman MJ; Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
  • Heymach JV; Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Govindan R; Medical Oncology, Washington University School of Medicine, St Louis, Missouri, USA.
  • Bachier C; Hematology, Sarah Cannon Center for Blood Cancer at TriStar Centennial, Nashville, Tennessee, USA.
  • Doger de Spéville B; START Madrid-FJD, Fundación Jiménez Díaz University Hospital, Madrid, Spain.
  • Frigault MJ; Bone Marrow Transplant & Cellular Therapy, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Olszanski AJ; Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
  • Lam VK; Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Hyland N; Adaptimmune, Milton Park, Abingdon, Oxfordshire, UK.
  • Navenot JM; Adaptimmune, Philadelphia, Pennsylvania, USA.
  • Fayngerts S; Adaptimmune, Philadelphia, Pennsylvania, USA.
  • Wolchinsky Z; Adaptimmune, Milton Park, Abingdon, Oxfordshire, UK.
  • Broad R; Adaptimmune, Milton Park, Abingdon, Oxfordshire, UK.
  • Batrakou D; Adaptimmune, Milton Park, Abingdon, Oxfordshire, UK.
  • Pentony MM; Adaptimmune, Milton Park, Abingdon, Oxfordshire, UK.
  • Sanderson JP; Adaptimmune, Milton Park, Abingdon, Oxfordshire, UK.
  • Gerry A; Adaptimmune, Milton Park, Abingdon, Oxfordshire, UK.
  • Marks D; Adaptimmune, Philadelphia, Pennsylvania, USA.
  • Bai J; Adaptimmune, Philadelphia, Pennsylvania, USA.
  • Holdich T; Adaptimmune, Milton Park, Abingdon, Oxfordshire, UK.
  • Norry E; Adaptimmune, Philadelphia, Pennsylvania, USA.
  • Fracasso PM; Adaptimmune, Philadelphia, Pennsylvania, USA.
J Immunother Cancer ; 10(1)2022 01.
Article em En | MEDLINE | ID: mdl-35086946
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Linfócitos T / Imunoterapia Adotiva / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Antígenos de Neoplasias / Proteínas de Neoplasias Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Linfócitos T / Imunoterapia Adotiva / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Antígenos de Neoplasias / Proteínas de Neoplasias Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos